SRI KRISHNA SURGICALS PHARMA

SRI Krishna Surgical Pharma lists vegetables, orchids, and starchy roots as core products — a mix that is unusual for a pharma company, suggesting possible diversification into horticultural or agricultural supply chains. Targeting the United States means they are likely aiming at buyers in the medical, botanical, or specialty farming sectors. The lack of verified contact details — including work email, phone, and documents — raises red flags about legitimacy and trustworthiness. Buyers should verify the company's actual operations before placing any orders, especially given the mismatch between a pharma name and a plant-based product list. Without annual turnover or financial data, it's hard to assess scale or reliability. This combination of a pharma name with agricultural products and unverified credentials may signal a risk of misrepresentation or a new entrant without established trade history.